Old Mission Capital’s Integra LifeSciences IART Stock Holding History

Old Mission Capital’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,603	Closed	-$354K	–	1415
2023 Q2	$354K	Buy	+8,603	New	+$414K	0.01%	772
2021 Q2	–	Sell	-10,410	Closed	-$719K	–	1119
2021 Q1	$719K	Buy	+10,410	New	+$705K	0.04%	433

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Old Mission Capital's IART Position: Q3 2023 in Review

Old Mission Capital sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 8,603 shares — an estimated $354K sold.

Old Mission Capital first reported a position in IART in Q1 2021 and held it in 2 quarters. The position peaked at $719K in Q1 2021. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

Old Mission Capital reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
Old Mission Capital sold 8,603 Integra LifeSciences shares in Q3 2023, an estimated $354K.
Old Mission Capital first reported a position in Integra LifeSciences in Q1 2021 and held it in 2 quarters.
Old Mission Capital's Integra LifeSciences position peaked at $719K in Q1 2021.
262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Old Mission Capital's 13F filing for Q3 2023, filed 15 Nov 2023.